3 April 2025

Last updated: Sunday 30 March 2025

Research Directory

Pharma invests in R&D across a broad front

Oncology approvals rise, driven by novel compounds

Hot targets in immuno-oncology

Insect-derived peptides - next generation antibiotics?

Phosphatases rise from the ashes

Swiss biotech attracted record financing in 2020

The data-driven autobahn to cures

Covid-19 and the future of diagnostics

A new strategy for regenerating damaged tissue

Leyden Labs plans to protect against viral infections